822. Misbranding of Clearwater's Combination Medicine. U. S. v. Henry P. Clear-
water (H. P. Clearwater and Pope Laboratories). Plea of nolo contendere.
Fine, $150.     (P. D. C. No. 5574.    Sample Nos. 24345-E, 26965-E.)
On March 17, 1942, the United States attorney for the District of Maine filed
an information against Henry P. Clearwater, trading as H. P. Clearwater and
Pope Laboratories, Hallowell, Maine, alleging shipment on or about July 18 and
August 12, 1940, from the State of Maine into the States of Pennsylvania ax
Washington of quantities of Clearwater's Combination Medicine whTcTTw^smis-
branded.
The /combination consisted of three products. Analysis showed that No. 1
was a pink pill consisting essentially of ferrous carbonate, potassium iodide,
calcium glycerophosphate, manganese dioxide, sulfur, and a compound of zinc;
that No. 2 was a white tablet containing cascara; and that No. 3 was a pink
compressed tablet consisting largely of aspirin and starch.
The article was alleged to be misbranded in that certain statements in the
labeling which represented and suggested that it would be efficacious as a reconr
structive systemic tonic and would be efficacious in the treatment and pre-
vention of rheumatism and arthritis were false and misleading since it would
not be efficacious for such purposes.
On July 16, 1942, the defendant entered a plea of nolo contendere and the
court imposed a fine of $150.